Page 97 - Strategies for non-invasive managementof high-grade cervical intraepithelial neoplasia - prognostic biomarkers and immunotherapy Margot Maria Koeneman
P. 97

at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to
invasive cancer. J Pathol. 2006;210(4):412-9.
16. Wright TC, Compagno J, Romano P, Grazioli V, Verma Y, Kershnar E, et al. Amplification of
the 3q chromosomal region as a specific marker in cervical cancer. Am J Obstet Gynecol.
2015;213(1):51 e1-8.
17. Pepe MS, Feng Z, Janes H, Bossuyt PM, Potter JD. Pivotal evaluation of the accuracy of a
biomarker used for classification or prediction: standards for study design. J Natl Cancer
Inst. 2008;100(20):1432-8. 4
18. Hopman AH, van Hooren E, van de Kaa CA, Vooijs PG, Ramaekers FC. Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely
processed bladder cancers. Mod Pathol. 1991;4(4):503-13.
19. Pahlplatz MM, de Wilde PC, Poddighe P, van Dekken H, Vooijs GP, Hanselaar AG. A model
for evaluation of in situ hybridization spot-count distributions in tissue sections. Cytometry.
1995;20(3):193-202.
20. Heselmeyer-Haddad K, Sommerfeld K, White NM, Chaudhri N, Morrison LE, Palanisamy N,
et al. Genomic amplification of the human telomerase gene (TERC) in pap smears predicts
the development of cervical cancer. Am J Pathol. 2005;166(4):1229-38.
21. Alameda F, Espinet B, Corzo C, Munoz R, Bellosillo B, Lloveras B, et al. 3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-
grade squamous intraepithelial lesion cases. Hum Pathol. 2009;40(10):1474-8.
22. Jalali GR, Herzog TJ, Dziura B, Walat R, Kilpatrick MW. Amplification of the chromosome 3q26 region shows high negative predictive value for nonmalignant transformation of LSIL
cytologic finding. Am J Obstet Gynecol. 2010;202(6):581 e1-5.
23. Lan YL, Yu L, Jia CW, Wu YM, Wang SY. Gain of human telomerase RNA gene is associated
with progression of cervical intraepithelial neoplasia grade I or II. Chin Med J (Engl).
2012;125(9):1599-602.
24. Rodolakis A, Biliatis I, Symiakaki H, Kershnar E, Kilpatrick MW, Haidopoulos D, et al. Role of
chromosome 3q26 gain in predicting progression of cervical dysplasia. Int J Gynecol Cancer.
2012;22(5):742-7.
25. Obermann EC, Savic Prince S, Barascud A, Grilli B, Herzog M, Kaup D, et al. Prediction of
outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC. Cancer Cytopathol. 2013;121(8):423-31.
26. Li L, Jiang W, Zeng SY, Li L. Prospective study of hTERC gene detection by fluorescence in situ hybridization (FISH) in cervical intraepithelial neoplasia 1 natural prognosis. Eur J Gynaecol Oncol. 2014;35(3):289-91.
27. Ravaioli S, Tumedei MM, Amadori A, Puccetti M, Chiadini E, Bravaccini S. Role of Telomerase in Cervical Lesions as Prognostic Marker: A Comparison Between Immunohistochemistry and Fluorescence In Situ Hybridization. J Low Genit Tract Dis. 2017;21(1):42-6.
28. Olaharski AJ, Sotelo R, Solorza-Luna G, Gonsebatt ME, Guzman P, Mohar A, et al. Tetraploidy and chromosomal instability are early events during cervical carcinogenesis. Carcinogenesis. 2006;27(2):337-43.
3q26 as a prognostic biomarker
 95


































































   95   96   97   98   99